FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

387480006: Lidocaine (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1461658013 Lidocaine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481571013 Lidocaine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1492109015 Lignocaine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1461658013 Lidocaine (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1461658013 Lidocaine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481571013 Lidocaine en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1481571013 Lidocaine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1492109015 Lignocaine en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1492109015 Lignocaine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
56381000195118 lidocaina it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
71381000195111 Lidocain de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
820781000172112 lidocaïne fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
820781000172112 lidocaïne fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
56381000195118 lidocaina it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
71381000195111 Lidocain de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lidocaine Is a Class Ib antiarrhythmic agent (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Lidocaine Is a Amide type local anesthetic false Inferred relationship Existential restriction modifier (core metadata concept)
Lidocaine Is a Local anesthetic (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Lidocaine Is a Amide and/or amide derivative false Inferred relationship Existential restriction modifier (core metadata concept)
Lidocaine Has disposition Sodium channel blocker true Inferred relationship Existential restriction modifier (core metadata concept)
Lidocaine Is a Substance with sodium channel blocker mechanism of action (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Lidocaine Is a Amide local anesthetic (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Poisoning caused by lidocaine (disorder) Causative agent (attribute) True Lidocaine Inferred relationship Existential restriction modifier (core metadata concept) 1
Lidocaine measurement Component True Lidocaine Inferred relationship Existential restriction modifier (core metadata concept) 1
Accidental lignocaine poisoning Causative agent (attribute) False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Intentional lignocaine poisoning (disorder) Causative agent (attribute) False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lignocaine poisoning of undetermined intent Causative agent (attribute) False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept) 1
Lignocaine adverse reaction (disorder) Causative agent (attribute) True Lidocaine Inferred relationship Existential restriction modifier (core metadata concept) 1
Allergy to lidocaine (finding) Causative agent (attribute) False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lignocaine overdose (disorder) Causative agent (attribute) True Lidocaine Inferred relationship Existential restriction modifier (core metadata concept) 1
Accidental lignocaine overdose (disorder) Causative agent (attribute) True Lidocaine Inferred relationship Existential restriction modifier (core metadata concept) 1
Intentional lignocaine overdose (disorder) Causative agent (attribute) True Lidocaine Inferred relationship Existential restriction modifier (core metadata concept) 1
Lignocaine overdose of undetermined intent Causative agent (attribute) False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept) 1
Lignocaine hydrochloride [antiarrhythmic] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lignocaine hydrochloride [eye] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lidocaine 20 mg/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lignocaine+prilocaine 2.5%/2.5% cream+occlusive dressing (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lignocaine+prilocaine 2.5%/2.5% cream (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lignocaine HCl [anesthesia] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lignocaine [generic addit] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lignocaine hydrochloride 100mg/10mL(1%) prefilled syringe (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lignocaine hydrochloride 2% dental cartridge (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lignocaine hydrochloride 100mg/5mL(2%) prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely lidocaine hydrochloride 50 milligram/1 milliliter and phenylephrine hydrochloride 5 milligram/1 milliliter conventional release solution for cutaneous spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lignocaine hydrochloride+adrenaline 0.5%/1:200,000 injection (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lidocaine hydrochloride 2% throat spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely lidocaine hydrochloride 5 milligram/1 gram conventional release cutaneous gel (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter conventional release cutaneous gel (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lignocaine hydrochloride 2% gel (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely lidocaine hydrochloride 50 milligram/1 gram conventional release gingival ointment (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lidocaine 10 mg/actuation oromucosal spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely lidocaine hydrochloride 40 milligram/1 milliliter conventional release cutaneous solution (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lidocaine hydrochloride+epinephrine 2%/1:80,000 cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lidocaine hydrochloride+fluorescein sodium 4%/0.25% single-use eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing epinephrine and lidocaine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing chlorhexidine and lidocaine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine Inferred relationship Existential restriction modifier (core metadata concept) 2
Lignocaine+fluorescein (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine Inferred relationship Existential restriction modifier (core metadata concept) 1
Lignocaine hydrochloride+glucose (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing lidocaine and prilocaine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine Inferred relationship Existential restriction modifier (core metadata concept) 2
Lidocaine 1.5% injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lignocaine hydrochloride+chlorhexidine 1%/0.25% gel (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lignocaine hydrochloride+chlorhexidine 2%/0.25% gel (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lignocaine hydrochloride+glucose 0.1%/5% infusion (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lignocaine hydrochloride+glucose 0.2%/5% infusion (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lidocaine hydrochloride 0.4%/glucose 5% infusion solution bag The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lignocaine hydrochloride+glucose 0.6%/5% infusion (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lignocaine hydrochloride 1% sterile wrapped injection (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lignocaine hydrochloride 2% sterile wrapped injection (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lignocaine hydrochloride 4% injection (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lidocaine hydrochloride heavy 5% injection solution sterile ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lignocaine hydrochloride 0.5% injection amp (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lignocaine hydrochloride 1% injection amp (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lignocaine hydrochloride 2% injection amp (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lidocaine hydrochloride 1% injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lignocaine hydrochloride 2% injection vial (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lignocaine hydrochloride+adrenaline 4% preservative free nasal drops (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lignocaine hydrochloride+glucose 0.2%/5% Polyfusor (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lignocaine hydrochloride+glucose 0.4%/5% Polyfusor (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lignocaine hydrochloride 2% solution (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lidocaine hydrochloride 40mg/mL(4%) sterile solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
IV Lignocaine (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Local lignocaine injection (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Topical lidocaine (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lignocaine hydrochloride+adrenaline 1%/1:200,000 injection (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lignocaine hydrochloride+adrenaline 2%/1:200,000 injection (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing lidocaine and phenylephrine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine Inferred relationship Existential restriction modifier (core metadata concept) 2
Lidocaine hydrochloride 1.5%/epinephrine 1:200,000 injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lidocaine hydrochloride 2%/epinephrine 1:500,000 injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lidocaine hydrochloride+epinephrine 2%/1:100,000 injection (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely lidocaine hydrochloride 30 milligram/1 milliliter conventional release cutaneous cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lidocaine hydrochloride 100mg/mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lidocaine 46.1mg/unt The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lidocaine hydrochloride 12mg/dose spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lidocaine 50 microgram/mg cutaneous patch The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lidocaine hydrochloride 1.5% injection (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lidocaine hydrochloride 0.5% injection (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lidocaine hydrochloride 40mg/mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lidocaine hydrochloride 4% solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lidocaine 5% solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lidocaine hydrocarbonate 10mg/mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Dextrose + lidocaine hydrochloride 75mg/50mg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Epinephrine + lidocaine hydrochloride 0.01mg/20mg injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Epinephrine 20mcg/lidocaine hydrochloride 20mg injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Epinephrine + lidocaine hydrochloride 10mcg/10mg injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Epinephrine + lidocaine hydrochloride 10mcg/20mg injecti The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Epinephrine + lidocaine hydrochloride 20mcg/20mg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Epinephrine 5mcg/lidocaine hydrochloride 15mg injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Epinephrine bitartrate + lidocaine hydrochloride 0.005mg/10mg injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Epinephrine bitartrate + lidocaine hydrochloride 10mcg/20mg inj The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Epinephrine bitartrate + lidocaine hydrochloride 20mcg/20mg inj The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lidocaine + prilocaine 25mg/25mg cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lidocaine hydrochloride 5%/glucose 7.5% injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lidocaine hydrochloride 1%/epinephrine 1:100,000 injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Dextrose 7.5%ww/lidocaine hydrochloride 1.5%ww injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing lidocaine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine Inferred relationship Existential restriction modifier (core metadata concept) 1
Methylprednisolone acetate+lignocaine hydrochloride 80/20mg/2mL injection (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
acétate de méthylprednisolone et chlorhydrate de lidocaïne 40/10 mg/1 mL pour injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing lidocaine and methylprednisolone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine Inferred relationship Existential restriction modifier (core metadata concept) 2
Oxytetracycline+lidocaine 50mg/mL/2% injection 2mL ampoule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Oxytetracycline+lidocaine 50mg/mL/2% injection 10mL ampoule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Oxytetracycline+lidocaine 125mg/mL/2% injection 2mL ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)
Lidocaine- and oxytetracycline-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Lidocaine Inferred relationship Existential restriction modifier (core metadata concept) 2
Domiphen bromide+lidocaine hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lidocaine Inferred relationship Existential restriction modifier (core metadata concept)

Page 1 of 3 Next End

This concept is not in any reference sets

Back to Start